Navigation Links
Iowa State researchers look for smaller, cheaper, 1-dose vaccines
Date:1/15/2008

A team of Iowa State University researchers is examining a new vaccine method that may change the way we get vaccinations.

Michael Wannemuehler and his team of researchers is hoping to find a way to produce vaccines that work better, use smaller doses and require only one trip to the doctor's office.

Traditionally, injectable vaccines have often been prepared from killed bacteria. The vaccinated person's immune system then learns to recognize the bacteria as a threat and consequently builds up defenses against it. Then, if the individual is exposed to the live version of the infectious agent, his or her body is already prepared to defend itself.

Wannemuehler's research is focused on the use of just a part of the bacteria -- a protein -- as a vaccine, instead of the entire bacteria, coupled with novel polymers that will be used to deliver these vaccines. This combination of new approaches will allow vaccines doses to be smaller, safer and induce fewer side effects.

"As we move away from using whole bacteria, we're going to more molecular approaches with purified proteins or portions of proteins," said Wannemuehler, a professor of veterinary microbiology and preventative medicine. "What these technologies should allow us to do is, instead of injecting 100 units to get protection, we can inject one unit, for example."

Wannemuehler's research targets the bacteria that causes plague, a disease that's rare in the United States, but is still found in other parts of the world.

Using select proteins of the bacteria coupled with unique polymers can reduce the amount of vaccine needed as well as costs for shipping and storage. That makes the vaccine economically feasible for areas at a great distance, such as Africa, where vaccines can be difficult to obtain.

Also, vaccinating a large population can be difficult if more than one dose or injection is required. In places where doctors are scarce, locating and vaccinating patients can be difficult. In addition, having the same patients return for their booster vaccinations can be even more complicated.

"Another aspect is the hope that this would be single dose," said Wannemuehler. "We hope we can get a robust response with one dose."

And there will likely be uses beyond the plague.

"If this technology works here," said Wannemuehler, "it's completely transferable to any protein, with minor changes."

Wannemuehler is working with BioProtection Systems Corp. of Ames on this research. BPSC hopes to supply lower-cost vaccines to government agencies for use where the plague is still a threat.

"We are thankful that the Iowa Values Fund supports our collaboration with Iowa State University and allows us to combine our broadly applicable vaccine technology with theirs for the development of more effective vaccines," said Joe Lucas of BPSC, located at the Iowa State University Research Park.


'/>"/>

Contact: Michael Wannemuehler
mjwannem@iastate.edu
515-294-7074
Iowa State University
Source:Eurekalert

Related biology news :

1. Ingram Micro to Distribute New Fujitsu Biometric Login Products for Novell eDirectory in United States
2. LSU and Ohio State battle on football field, collaborate in research field
3. Poor Americans in the United States suffer hidden burden of parasitic and other neglected diseases
4. Emory, Ohio State launch partnership in predictive and personalized health care
5. Tiny dust particles from Asian deserts common over western United States
6. K-State specialist in tick-borne pathogens receives $1.8 million grant
7. K-State researchers findings on E. coli
8. Study of malaria parasite in patient blood finds distinct physiological states
9. Safeway Inc. and PCF to fund landmark prostate cancer research collaboration
10. First-ever State of the Carbon Cycle Report finds troubling imbalance
11. Proteins pack tighter in crowded native state
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... -- Hunova, the first robotic gym for the rehabilitation and functional motor sense ... Genoa, Italy . The first 30 robots will be available ... USA . The technology was developed and patented at the IIT ... Movendo Technology thanks to a 10 million euro investment from entrepreneur Sergio ... ...
(Date:5/16/2017)... May 16, 2017  Veratad Technologies, LLC ( www.veratad.com ... age and identity verification solutions, announced today they will ... 2017, May 15 thru May 17, 2017, in ... International Trade Center. Identity impacts the ... in today,s quickly evolving digital world, defining identity is ...
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
Breaking Biology News(10 mins):
(Date:5/26/2017)... ... 2017 , ... Activate Healthcare, a leading provider of on-site ... growing private companies, has selected Twine for its Employee Health Activation Platform. Activate ... model that empowers deep collaboration and behavior change. In randomized controlled trials, Twine ...
(Date:5/26/2017)... ... May 25, 2017 , ... Throughout this ... studies, describing how process development and economic goals were achieved in both industry ... a hollow-fiber bioreactor system, along with techniques for scaling production of mesenchymal stem ...
(Date:5/26/2017)... ... 25, 2017 , ... Studying biological events while they happen ... imaging using fluorescence microscopy is the perfect approach to explore these complex questions. ... be discussed, from small animal models and tissues to individual organelle and protein ...
(Date:5/26/2017)... ... May 25, 2017 , ... LabRoots , the leading ... scientists from around the world, is announcing a new textbook scholarship, the second scholarship ... and graduate students, 17 years or older, pursuing a degree in one of the ...
Breaking Biology Technology: